Parkwood LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25M Buy
163,364
+16,104
+11% +$2.47M 2.21% 7
2025
Q4
$20.3M Buy
147,260
+14,294
+11% +$1.87M 1.73% 18
2025
Q3
$17.1M Sell
132,966
-94,334
-42% -$11.5M 1.66% 17
2025
Q2
$27.5M Buy
227,300
+120,923
+114% +$13.6M 2.53% 6
2025
Q1
$11.9M Sell
106,377
-11,614
-10% -$1.24M 1.16% 38
2024
Q4
$11.5M Buy
+117,991
New +$12.6M 1.41% 20
2020
Q4
Sell
-59,078
Closed -$5.14M 126
2020
Q3
$5.14M Buy
59,078
+1,506
+3% +$130K 0.93% 41
2020
Q2
$5.03M Sell
57,572
-64,545
-53% -$5.57M 0.95% 35
2020
Q1
$10.1M Buy
122,117
+49,818
+69% +$4.44M 2.39% 10
2019
Q4
$6.85M Buy
72,299
+2,809
+4% +$252K 1.44% 23
2019
Q3
$6.04M Sell
69,490
-64,909
-48% -$5.83M 1.22% 23
2019
Q2
$12.3M Buy
134,399
+58,903
+78% +$4.99M 2.62% 8
2019
Q1
$6.5M Sell
75,496
-86,210
-53% -$6.92M 1.27% 23
2018
Q4
$12.4M Buy
161,706
+79,197
+96% +$6.16M 2.85% 7
2018
Q3
$6.37M Buy
82,509
+768
+0.9% +$56.8K 1.08% 27
2018
Q2
$5.53M Sell
81,741
-1,911
-2% -$132K 0.87% 32
2018
Q1
$6.06M Buy
83,652
+18,213
+28% +$1.39M 0.87% 35
2017
Q4
$4.92M Buy
65,439
+406
+0.6% +$30.6K 0.67% 40
2017
Q3
$5M Buy
65,033
+6,649
+11% +$502K 0.74% 40
2017
Q2
$4.37M Buy
58,384
+28,593
+96% +$2.03M 0.65% 41
2017
Q1
$1.98M Sell
29,791
-9,683
-25% -$645K 0.28% 80
2016
Q4
$2.58M Buy
39,474
+5,694
+17% +$369K 0.4% 64
2016
Q3
$2.39M Sell
33,780
-3,273
-9% -$239K 0.35% 70
2016
Q2
$2.74M Buy
37,053
+1,071
+3% +$74K 0.46% 60
2016
Q1
$2.34M Buy
35,982
+29,966
+498% +$2.04M 0.39% 59
2015
Q4
$464K Buy
6,016
+882
+17% +$70.1K 0.07% 271
2015
Q3
$423K Sell
5,134
-70
-1% -$6.23K 0.07% 213
2015
Q2
$459K Buy
5,204
+86
+2% +$7.89K 0.06% 209
2015
Q1
$452K Buy
+5,118
New +$454K 0.06% 244
2014
Q4
Sell
-6,228
Closed -$525K 509
2014
Q3
$525K Sell
6,228
-4,474
-42% -$362K 0.11% 83
2014
Q2
$868K Buy
+10,702
New +$842K 0.2% 66

Other funds holding NVS